Social economic costs and health-related quality of life in patients with amyotrophic lateral sclerosis in Spain

Amyotrophic Lateral Sclerosis

Volumn 10, Issue 4, 2009, Pages 237-243

  López Bastida, Julio ^a,b,c   Perestelo Pérez, Lilisbeth ^a,c   Montón Álvarez, Fernando ^b   Serrano Aguilar, Pedro ^a,c   Alfonso Sanchez, Jose Luis ^d  

^a Canary Health Service   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Amyotrophic lateral sclerosis; Cost of illness; Quality of life; Spain

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CAREGIVER; CROSS-SECTIONAL STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RETIREMENT; SPAIN;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; CAREGIVERS; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; SPAIN;

EID: 70249105017     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/17482960802430781     Document Type: Article

References (31)

1. Borasio GD, Miller RG. Clinical characteristics and management of ALS. Seminar in Neurology 2001;21:155-66.
2. Perestelo-Pérez L, Duran E, Baena N, Gravila D, González M, Arizo V. Estimación de la mínima prevalencia detectada de las enfermedades espinocerebelosas y de la esclerosis lateral amiotrófica en España a partir del CMBD. Gac Sanit 2004;18(Suppl 3):66.
3. Damiano A, Patrick D, Guzmán G, Gawel M, Gelinas D, Natter H, et al. Measurement of health-related quality of life in patients with amyotrophic lateral sclerosis in clinical trials of new therapies. Med Care 1999;37:15-26.
4. Mitsumoto H, Rabkin JG. Palliative care for patients with amyotrophic lateral sclerosis: "prepare for the worst and hope for the best". JAMA 2007;11;298:207-16.
5. Kiebert G, Green C, Murphy C, Mitchell J, O'Brien M, Burrell A, et al. Patients' health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis. J Neurol Sci 2001;191:87-93.
6. Simmons Z, Bremer BA, Robbins RA, Walsh SM, Fischer S. Quality of life in ALS depends on factors other than strength and physical function. Neurology 2000;55:388-92.
7. Robbins RA, Simmons Z, Bremer BA, Walsh SM, Fischer S. Quality of life in ALS is maintained as physical function declines. Neurology 2001;56:442-4.
8. Gauthier A, Vignola A, Calvo A, Cavallo E, Moglia C, Sellitti L, et al. A longitudinal study on quality of life and depression in ALS patient-caregiver couples. Neurology 2007;68:923-6.
9. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the economic valuation of health care programmes, 2nd edn. New York: Oxford University Press; 1997.
10. Hodgson T, Meiners M. Cost-of-illness methodology: A guide to assessment practices and procedures. Millbank Mem Fund Q 1982;60:429-91.
11. Max W, Rice D, Mackenzie E. The lifetime cost of injury. Inquiry 1990;27:332-43.
12. SOIKOS. Base de datos de costes sanitarios SOIKOS. Barcelona: SOIKOS 2001.
13. Gold MR Siegel JE Russell LB Weinstein MC editors. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
14. McDaid D. Estimating the costs of informal care for people with Alzheimer's disease: Methodological and practical challenges. Int J Geriatr Psychiatry 2001;16:400-5.
15. Mishan E. Evaluation of life and limb: A theoretical approach. J Polit Econ 1971;79:687-705.
16. López-Bastida J, Serrano-Aguilar P, Duque B. The economic costs of traffic accidents in Spain. J Trauma 2004;56:883-9.
17. Koopmanschap MA, Rutten FFH, van Ineveld BM, van Roijen L. The friction cost method for measuring indirect cost of disease. J Health Econ 1995;14:171-89.
18. Instituto Nacional de Estadística. Encuesta de Estructura Salarial 2002a. Available at URL: www.ine.es/prensa/np347.pdf. (accessed 2007 Oct 13).
19. Instituto Nacional de Estadística. Encuesta de Población Activa 2002b. Available at URL: www.ine.es/daco/daco42/daco4211/epa0402.pdf. (accessed 2007 Oct 13).
20. Brooks R. EuroQol: The current state of play. Health Policy 1996;37:53-72.
21. Badia X, Schiaffino A, Alonso J, Herdman M. Using the EuroQol 5D in the Catalan general population: Feasibility and construct validity. Qual Life Res 1998;7:311-22.
22. Servicio Canario de la Salud. Encuesta de Salud de Canarias 2004. Santa Cruz de Tenerife: Consejería de Sanidad del Gobierno de Canarias; 2005. Available at: http://www.gobier nodecanarias.org/sanidad/scs/1/ plansalud/istac/estadisticas/salud_2004/salud2004.html. (accessed 2007 February 13).
23. Dolan P. Modelling valuations for EuroQol health states. Med Care 1997;35:1095-108.
24. Badia X, Roset M, Montserrat S, Herdman M, Segura A. The Spanish version of EuroQol: A description and its applications. European Quality of Life scale. Med Clin (Barc) 1999;112(Suppl 1):79-85.
25. Corcia P, Meininger V. Management of amyotrophic lateral sclerosis. Drugs 2008;68:1037-48.
26. López-Bastida J, Oliva J, Perestelo-Pérez L, Serrano-Aguilar P. Determinants of health care costs in ambulatory patients living with HIV/AIDS. Value Health 2005;8:23.
27. López-Bastida J, Serrano-Aguilar P, Montón F. The economic burden of stroke in Spain. Value Health 2003;6:615.
28. López-Bastida J, Perestelo Pérez L, Montón-Álvarez F, Serrano Aguilar P. Socioeconomic costs and health-related quality of life in patients with degenerative cerebellar ataxia in Spain. Movement Disorder 2008;23:212-7.
29. López-Bastida J, Serrano-Aguilar P, Perestelo-Pérez L, Oliva-Moreno J. Socioeconomic costs and quality of life with Alzheimer's disease in the Canary Islands, Spain. Neurology 2006;67:2186-91.
30. Green C, Kiebert G, Murphy C, Mitchell JD, O'Brien M, Burrell A, Leigh PN. Patients' health-related quality-of-life and health state values for motor neuron disease/amyotrophic lateral sclerosis. Quality of Life Research 2003;12:565-74.
31. Jenkinson C, Hobart J, Chandola T, Fitzpatrick R, Peto V, Swash M, et al. Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: Tests of data quality, score reliability, response rate and scaling assumptions. Journal of Neurology 2002;249:178-83.